Access cutting-edge sarcoma treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access sarcoma specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sarcoma treatment provided free
Background: The drug PEN-866 can remain in tumor cells longer than it does in normal cells. It also may be more effective than other drugs at treating Ewing sarcoma and rhabdomyosarcoma. Researchers want to learn if combining PEN-866 with other drugs can treat certain cancers in adolescents and young adults. Objective: To learn if the combination of PEN-866 with vincristine and temozolomide can be used to treat adolescents and young adults with solid tumors that have returned after or did not
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this sarcoma clinical trial in Washington Dc, DC
If you're searching for sarcoma treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.